- Home
- IPSC vs KORE Comparison
IPSC vs KORE Comparison
Compare IPSC & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- KORE
- Stock Information
- Founded
- IPSC 2019
- KORE 2003
- Country
- IPSC United States
- KORE United States
- Employees
- IPSC N/A
- KORE N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- KORE Telecommunications Equipment
- Sector
- IPSC Health Care
- KORE Consumer Discretionary
- Exchange
- IPSC Nasdaq
- KORE Nasdaq
- Market Cap
- IPSC 49.1M
- KORE 45.0M
- IPO Year
- IPSC 2021
- KORE N/A
- Fundamental
- Price
- IPSC $0.56
- KORE $4.50
- Analyst Decision
- IPSC Strong Buy
- KORE Hold
- Analyst Count
- IPSC 5
- KORE 2
- Target Price
- IPSC $3.33
- KORE $2.75
- AVG Volume (30 Days)
- IPSC 1.4M
- KORE 237.1K
- Earning Date
- IPSC 11-07-2025
- KORE 11-12-2025
- Dividend Yield
- IPSC N/A
- KORE N/A
- EPS Growth
- IPSC N/A
- KORE N/A
- EPS
- IPSC N/A
- KORE N/A
- Revenue
- IPSC $114,128,000.00
- KORE $285,636,000.00
- Revenue This Year
- IPSC $1,589.94
- KORE $4.46
- Revenue Next Year
- IPSC N/A
- KORE $5.94
- P/E Ratio
- IPSC N/A
- KORE N/A
- Revenue Growth
- IPSC 5491.77
- KORE 0.24
- 52 Week Low
- IPSC $0.34
- KORE $1.10
- 52 Week High
- IPSC $1.83
- KORE $4.88
- Technical
- Relative Strength Index (RSI)
- IPSC 48.92
- KORE 79.90
- Support Level
- IPSC $0.55
- KORE $3.35
- Resistance Level
- IPSC $0.65
- KORE $3.83
- Average True Range (ATR)
- IPSC 0.04
- KORE 0.34
- MACD
- IPSC -0.00
- KORE 0.09
- Stochastic Oscillator
- IPSC 18.00
- KORE 81.05
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.